Publications

Selected Publications

Hee Seung Lee, Dai Hoon Han, Kyungjoo Cho, Soo Been Park, Chanyang Kim, Galam Leem, Dawoon E. Jung, Soon Sung Kwon, Chul Hoon Kim, Jung Hyun Jo, Hye Won Lee, Si Young Song, Jun Yong Park. Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtyping, Nature communications, 2023, 1st author (IF : 17.694) 

Gurudatt NG, Gwak H, Hyun K-A, et al. Electrochemical detection and analysis of tumor-derived extracellular vesicles to evaluate malignancy of pancreatic cystic neoplasm using integrated microfluidic device. Biosens Bioelectron 2023;226:115124., Corresponding author (IF: 12.5)

Jeong MH, Son T, Tae YK, et al. Plasmon-enhanced single extracellular vesicle analysis for cholangiocarcinoma diagnosis. Adv Sci 2023;10:e2205148., Corresponding author (IF: 15.1)

Yoo H-B, Moon JW, Kim H-R, et al. A TEAD2-driven endothelial-like program shapes basal-like differentiation and metastasis of pancreatic cancer. Gastroenterology 2023. Available at: https://doi.org/10.1053/j.gastro.2023.02.049. 1st author (IF: 29.4)

Seung Joon Park, Hee Chan Yoo, Eunyong Ahn, Enzhi Luo, Yeabeen Kim, Yulseung Sung, Ya Chun Yu, Kibum Kim, Do Sik Min, Hee Seung Lee, Geum-Sook Hwang, Tae Jin Ahn, Junjeong Choi, Seungmin Bang, Jung Min Han. Park, S. J. et al. Enhanced glutaminolysis drives hypoxia-induced chemoresistance in pancreatic cancer. Cancer research, 2023, co-author (IF : 13.312) 

Hee Seung Lee, Eunyoung Kim, Jinyoung Lee, Seung Joon Park, Ho Kyoung Hwang, Chan Hee Park, Se-Young Jo, Chang Moo Kang, Seung-Mo Hong, Huapyong Kang, Jung Hyun Jo, In Rae Cho, Moon Jae Chung, Jeong Youp Park, Seung Woo Park, Si Young Song, Jung Min Han, Sangwoo Kim, Seungmin Bang. Profiling of conditionally reprogrammed cell lines for in vitro chemotherapy response prediction of pancreatic cancer, EBioMedicine, 2021, 1st author (IF : 11.205) 

Hee Chan Yoo, Seung Joon Park, Miso Nam, Juwon Kang, Kibum Kim, Joo Hye Yeo, Joon-Ki Kim, Yunkyung Heo, Hee Seung Lee, Myeong Youl Lee, Chang Woo Lee, Jong Soon Kang, Yun-Hee Kim, Jinu Lee, Junjeong Choi, Geum-Sook wang, Seungmin Bang, Jung Min Han. A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells, Cell metabolism, 2020, co-author (IF : 27.287) 

Hee Seung Lee, Sung Bae Kim, Hyun Jung Lee, Soo Jung Park, Sung Pil Hong, Jae Hee Cheon, Won Ho Kim, Tae Il Kim. Postoperative adjuvant chemotherapy is associated with a lower incidence of colorectal adenomas in patients with previous colorectal cancer. Gastrointest Endoscopy. 2017, Apr 18, 1st author (IF : 10.396) 

Publications (from 2019, main author)

Ko YG, Jo JH, Song SY, Lee HS. The crucial role of CEMIP in cancer metastasis: Mechanistic insights and clinical implications. FASEB J 2025;39:e70284.

Jo JH, Park SB, Chung J, et al. Transgelin-2, a novel cancer stem cell-related biomarker, is a diagnostic and therapeutic target for biliary tract cancer. BMC Cancer 2024;24:357.1st author

Hee Seung Lee, Wonjeong Chae, Min Je Sung, Jiyoung Keum, Jung Hyun Jo, Moon Jae Chung, Jeong Youp Park, Seung Woo Park, Si Young Song, Eun-Cheol Park, Chung Mo Nam, Sung-In Jang, Seungmin Bang. Difference of risk of pancreatic cancer in new-onset diabetes and long-standing diabetes: population-based cohort study, The Journal of Clinical Endocrinology & Metabolism, 2023, 1st author  (IF :  6.134) 

Yoon MS,  Lee HS, Kang CM, Lee WJ, Keum J, Sung MJ, Kim SS, Park MS, Jo JH, Chung MJ, Park JY, Park SW, Song SY, Hwang HK, Bang S. Response to Neoadjuvant Therapy and Prognosis in Patients with Resectable Pancreatic Cancer: A Propensity Score Matching Analysis. GUT AND LIVER. 2022. 1st author

Jo JH, Jung DE, Lee HS, et al. A phase I/II study of ivaltinostat combined with gemcitabine and erlotinib in patients with untreated locally advanced or metastatic pancreatic adenocarcinoma. Int J Cancer 2022;151:1565–1577.1st author

Lee HS, Leem G, Kang H, Jo JH, Chung MJ, Jang SJ, Yoon DH, Park JY, Park SW, Song SY, Bang S. Peripheral natural killer cell activity is associated with poor clinical outcomes in pancreatic ductal adenocarcinoma. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 2021. 1st author

Jo JH, Park SB, Park S, et al. Novel Gastric Cancer Stem Cell-Related Marker LINGO2 Is Associated with Cancer Cell Phenotype and Patient Outcome. Int J Mol Sci 2019;20. Available at: http://dx.doi.org/10.3390/ijms20030555.1st author

Paik WH, Lee HS, Lee KJ, Jang SI, Lee WJ, Hwang JH, Cho CM, Park CH, Han J, Woo SM, Jeong S, Chon HK, Kim TN, Lee JK, Han JH, Yoon JH, Kim YT, Cho JH.  Malignant potential of small pancreatic neuroendocrine neoplasm and its risk factors: A multicenter nationwide study, PANCREATOLOGY, 2021, 1st author

Gunn Huh*, Hee Seung Lee*, Jin Ho Choi, Sang Hyub Lee, Woo Hyun Paik, Ji Kon Ryu, Yong-Tae Kim, Seungmin Bang, Eaum Seok Lee. Gemcitabine plus Nab-paclitaxel as a second-line treatment following FOLFIRINOX failure in advanced pancreatic cancer: a multicenter, single-arm, open-label, phase 2 trial. Therapeutic advances in medical oncology, 2021, 1st author (IF : 5.02) 

Jiyoung Keum, Moon Jae Chung, Youngin Kim, Hyunyoung Ko, Min Je Sung, Jung Hyun Jo, Jeong Youp Park, Seungmin Bang, Seung Woo Park, Si Young Song, Hee Seung Lee. Usefulness of Smartphone Applications for Improving Nutritional Status of Pancreatic Cancer Patients: Randomized Controlled Trial. JMIR mHealth and uHealth, 2021, Corresponding author (IF : 4.95) 

Keum J, Lee HS, Kang H, Jo JH, Chung MJ, Park JY, Park SW, Song SY, Bang S. Single-center risk factor analysis for FOLFIRINOX associated febrile neutropenia in patients with pancreatic cancer. CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2020. 1st author

Lee HS, An C, Hwang HK, Roh YH, Kang H, Jo JH, Chung MJ, Park JY, Kang CM, Park SW, Yoon DS, Lee WJ, Song SY, Bang S. Preoperative prediction of futile surgery in patients with radiologically resectable or borderline resectable pancreatic adenocarcinoma. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020. 1st author

Lee HS, Kim SY, Chung MJ, Park JY, Bang S, Park SW, Song SY.  Skeletal Muscle Mass Predicts Poor Prognosis in Patients with Advanced Pancreatic Cancer Undergoing Second-Line FOLFIRINOX Chemotherapy, NUTRITION AND CANCER, 2019, 1st author

Lee HS, Lee JS, Lee J, Kim EK, Kim H, Chung MJ, Park JY, Park SW, Song SY, Bang S, Establishment of pancreatic cancer cell lines with endoscopic ultrasound‐guided biopsy via conditionally reprogrammed cell culture, CANCER MEDICINE, 2019, 1st author